Loading company…
NeuroXT develops AI software for medical imaging and treatment assessment.
NeuroXT's software uses AI to support biomarker-based diagnostics and treatment assessments from MRI scans. It is intended for healthcare facilities and practitioners. Founded in 2022, the company is based in Seoul, South Korea. In March 2025, it raised venture funding from Samsung Venture Investment and LG Corp.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in